WALTHAM, Mass.–(BUSINESS WIRE)–Scipher Medicine, a leader in precision immunology, today announced the public launch of ClinicalTrialRank.com, an innovative artificial intelligence (AI) platform engineered to predict clinical trial failure with...
NEW YORK & WALTHAM, Mass.–(BUSINESS WIRE)–Scipher Medicine, a leader in precision immunology, and Savant Bio, a Roivant-backed health data infrastructure company, today announced an expanded strategic partnership to build the world’s most advanced...
Novel “RA Response Calculator” Uses AI and Real Patient Data to Help Doctors Better Tailor Treatment Plans WALTHAM, MA – June 18, 2025 – At the European Congress of Rheumatology (EULAR) 2025, Scipher Medicine, the company behind the groundbreaking PrismRA® test,...
WALTHAM, Massachusetts – June 16, 2025 Scipher Medicine, a leading precision immunology company, today announced a strategic alliance with Grupo Amarey, a leading company in the representation and distribution of technologies, solutions, and services for the...
Partnership integrates Scipher’s PrismRA to deliver insights into therapy response segmentation WALTHAM, Mass.–(BUSINESS WIRE)–Scipher Medicine, a precision immunology company dedicated to transforming patient care through data-driven insights, today...
Collaboration combines Scipher’s unique RNAseq data, part of the largest non-oncology clinico-transcriptomic data lake and biobank, with InnoSIGN’s proprietary Comprehensive Pathway Analysis (CPA) platform to enhance the understanding of complex...
